Dyax Corp (DYAX)
38.04 -0.37 (-0.96%) 01/22/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Jan 22nd, 2016
Results
download Want to compare other data? Select Fields| Symbol | DYAX | TGTX | TLX | ||
| Company | Dyax Corp | Tg Therapeutics | Telix Pharmaceuticals Limited ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.04 | 36.36 | 16.25 | ||
| High | 38.04 | 36.78 | 17.00 | ||
| Low | 38.04 | 35.29 | 16.25 | ||
| Last | 38.04 | 36.71 | 16.65 | ||
| Change | -0.37 | +0.73 | +0.25 | ||
| % Change | -0.96% | +2.03% | +1.52% | ||
| Volume | 400 | 2,053,800 | 19,600 | ||
| 20-Day Average Volume | 3,916,305 | 2,854,040 | 27,485 | ||
| Previous Close | 38.41 | 35.98 | 16.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 37.87 | 39.48 | 16.72 | ||
| 20-Day Raw Stochastic | 51.85% | 46.35% | 57.95% | ||
| 20-Day Relative Strength | 66.28% | 49.51% | 48.88% | ||
| Weighted Alpha | +77.40 | +124.63 | N/A | ||
| Today's Opinion | N/A | 80% Buy | N/A | ||
| Previous Opinion | N/A | 80% Buy | N/A | ||
| Last Month's Opinion | N/A | 100% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.13% since 01/15/16 | -1.71% since 04/04/25 | +22.34% since 04/04/25 | ||
| Low | 38.04 on 01/22/16 | 31.00 on 04/09/25 | 13.71 on 04/07/25 | ||
| High | 38.56 on 01/21/16 | 38.87 on 04/08/25 | 17.15 on 04/10/25 | ||
| 1-Month | |||||
| %Chg | +0.93% since 12/22/15 | -2.24% since 03/11/25 | -0.60% since 03/11/25 | ||
| Low | 37.48 on 12/28/15 | 31.00 on 04/09/25 | 13.61 on 04/04/25 | ||
| High | 38.56 on 01/21/16 | 43.32 on 03/24/25 | 18.86 on 03/21/25 | ||
| 3-Month | |||||
| %Chg | +42.74% since 10/22/15 | +27.11% since 01/10/25 | +13.81% since 01/10/25 | ||
| Low | 26.53 on 10/23/15 | 27.24 on 01/13/25 | 13.61 on 04/04/25 | ||
| High | 38.56 on 01/21/16 | 43.32 on 03/24/25 | 30.36 on 02/24/25 | ||
| 6-Month | |||||
| %Chg | +41.78% since 07/22/15 | +65.51% since 10/11/24 | N/A since 11/14/24 | ||
| Low | 17.40 on 09/29/15 | 21.82 on 10/14/24 | 13.61 on 04/04/25 | ||
| High | 38.56 on 01/21/16 | 43.32 on 03/24/25 | 30.36 on 02/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,638,660 | 5,766,076 | 5,622,871 | ||
| Shares Outstanding, K | 146,360 | 157,071 | 337,710 | ||
| Annual Sales | 81,720,000 | 329,000,000 | 516,680,000 | ||
| Annual Net Income | -11,880,000 | 23,380,000 | 32,930,000 | ||
| Last Quarter Sales | 24,730,000 | 108,190,000 | N/A | ||
| Last Quarter Net Income | -11,700,000 | 23,330,000 | N/A | ||
| 60-Month Beta | 1.41 | 2.14 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 10/28/15 | 0.15 on 03/03/25 | N/A | ||
| Latest Earnings Date | 02/23/16 | 05/07/25 | 05/15/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 257.00 | 0.00 | ||